An online Mediterranean diet program for people with Parkinson's disease
Tests an online Mediterranean diet program in adults with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's Disease
Key facts
- Where
- Belfast, United KingdomSee the site
Where in United Kingdom
- Remote assessments from Centre for Public Health, Queens University BelfastBelfast, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Queen's University, Belfast
- Trial code
- NCT07838675
- Record updated
- 26 October 2026
- Original description
The aim of this pilot study is to assess whether an online Mediterranean diet programme called MediPD is acceptable and practical for people living with Parkinson's disease, and whether it can help them make and maintain changes towards a Mediterranean-style diet.Read full original descriptionShow less
Feasibility Of An Online Self-management Mediterranean Diet Program To Improve Dietary Behaviour And Quality Of Life For People Living With Parkinson's Disease: The MediPD Pilot Randomised Controlled Trial
The aim of this pilot study is to assess whether an online Mediterranean diet programme called MediPD is acceptable and practical for people living with Parkinson's disease, and whether it can help them make and maintain changes towards a Mediterranean-style diet.
The study will include 120 adults living in the United Kingdom with Parkinson's disease who have access to an internet-enabled device and currently have low adherence to a Mediterranean-style diet. Participants will be randomly assigned to one of two groups. One group will receive access to the MediPD online programme, which includes short educational videos, personalised dietary information, practical resources, goal-setting tools, and online dietetic support. The other group will continue with their usual care and will receive access to MediPD after completing the final study assessment.
Researchers will compare the groups to see whether MediPD improves adherence to a Mediterranean diet after 24 weeks. The study will also examine dietary intake, non-motor symptoms, quality of life, gastrointestinal symptoms, cognitive function, and how acceptable and practical the programme is to use. Assessments will take place at the start of the study, at 12 weeks, and at 24 weeks.
Inclusion: Self-reported idiopathic Parkinson's disease; Age 18 years or older; Community-dwelling and resident in the United Kingdom; Access to an internet-enabled device and an active email address; Mediterranean Diet Score ≤7/13, indicating low adherence to a Mediterranean diet; Proficient in English; Able to provide informed consent.
Exclusion: Receiving prescribed nutritional support; Participation in an investigational medicinal product trial within the previous 90 days where this may affect study outcomes or participant burden; Previous participation in a My Moves Matter dietary programme; Significant cognitive impairment, defined as T-CogS ≤21; Active inflammatory bowel disease; Food allergies that would prevent adherence to a Mediterranean-style diet; Atypical or secondary parkinsonism; Living in an institution; Self-reported body mass index <18.5 kg/m²; High risk of malnutrition, defined as MUST score ≥2; Pregnancy; Dysphagia requiring a pureed diet; Following a vegan diet that would prevent adherence to the study's Mediterranean-style dietary intervention; Current participation in another interventional trial.